Cargando…
Jingfukang induces anti-cancer activity through oxidative stress-mediated DNA damage in circulating human lung cancer cells
BACKGROUND: Metastasis is the main cause of lung cancer death. As a seed of metastasis, circulating tumor cells are an important target for metastasis intervention. The traditional Chinese medicine, Jinfukang, has been clinically available for the treatment of non-small cell lung cancer (NSCLC). In...
Autores principales: | Que, Zujun, Zhou, Zhiyi, Luo, Bin, Dong, Changsheng, Jiang, Yi, Li, Hegen, Tian, Jianhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686466/ https://www.ncbi.nlm.nih.gov/pubmed/31391058 http://dx.doi.org/10.1186/s12906-019-2601-x |
Ejemplares similares
-
Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
por: Que, Zujun, et al.
Publicado: (2019) -
Jinfukang inhibits clustering and invasion of circulating lung tumor cells by regulating the EGFR signaling pathway: Anti-metastatic mechanism of Jinfukang on lung cancer
por: Yang, Yun, et al.
Publicado: (2023) -
New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells
por: Que, Zujun, et al.
Publicado: (2022) -
Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer
por: Luo, Bin, et al.
Publicado: (2023) -
Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series
por: Luo, Bin, et al.
Publicado: (2022)